Cargando…
Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288423/ http://dx.doi.org/10.1186/2051-1426-2-S3-P122 |
| _version_ | 1782351969826897920 |
|---|---|
| author | Liu, Bai Kong, Lin Marcus, Warren D Chen, Xiaoyue Han, Kaiping Rhode, Peter R Wong, Hing C |
| author_facet | Liu, Bai Kong, Lin Marcus, Warren D Chen, Xiaoyue Han, Kaiping Rhode, Peter R Wong, Hing C |
| author_sort | Liu, Bai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288423 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42884232015-01-15 Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma Liu, Bai Kong, Lin Marcus, Warren D Chen, Xiaoyue Han, Kaiping Rhode, Peter R Wong, Hing C J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288423/ http://dx.doi.org/10.1186/2051-1426-2-S3-P122 Text en Copyright © 2014 Liu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Liu, Bai Kong, Lin Marcus, Warren D Chen, Xiaoyue Han, Kaiping Rhode, Peter R Wong, Hing C Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma |
| title | Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma |
| title_full | Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma |
| title_fullStr | Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma |
| title_full_unstemmed | Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma |
| title_short | Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma |
| title_sort | evaluation of a novel cd20-targeted il-15 immunotherapeutic with potent activity against b cell lymphoma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288423/ http://dx.doi.org/10.1186/2051-1426-2-S3-P122 |
| work_keys_str_mv | AT liubai evaluationofanovelcd20targetedil15immunotherapeuticwithpotentactivityagainstbcelllymphoma AT konglin evaluationofanovelcd20targetedil15immunotherapeuticwithpotentactivityagainstbcelllymphoma AT marcuswarrend evaluationofanovelcd20targetedil15immunotherapeuticwithpotentactivityagainstbcelllymphoma AT chenxiaoyue evaluationofanovelcd20targetedil15immunotherapeuticwithpotentactivityagainstbcelllymphoma AT hankaiping evaluationofanovelcd20targetedil15immunotherapeuticwithpotentactivityagainstbcelllymphoma AT rhodepeterr evaluationofanovelcd20targetedil15immunotherapeuticwithpotentactivityagainstbcelllymphoma AT wonghingc evaluationofanovelcd20targetedil15immunotherapeuticwithpotentactivityagainstbcelllymphoma |